Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes at one year following transplantation: Results from the NMDP sponsored ACCESS study

Blood (2025) 146 (Supplement 1): 936.

https://doi.org/10.1182/blood-2025-936

Published: 2025

Journal Articles

Reduced chronic graft versus host disease after allogeneic HSCT with cryopreserved peripheral blood stem cell grafts: A CIBMTR analysis

Alexandria Maurer, Tao Wang, Zachariah Defilipp, Jakob Devos, Nosha Farhadfar, Pooja Khandelwal, Stephen Spellman, Najla El Jurdi, Stephanie Lee, Robert Soiffer

Blood (2025) 146 (Supplement 1): 933.

https://doi.org/10.1182/blood-2025-933

Published: 2025

Journal Articles

Post-transplant cyclophosphamide based GVHD prophylaxis in HLA-matched related and unrelated donor hematopoietic cell transplantation in adults with hematologic malignancies undergoing myeloablative conditioning: A CIBMTR analysis of 8,272 participants

Pashna Munshi, Tao Wang, Shannon McCurdy, Rajneesh Nath, Cuyler Huffman, Nosha Farhadfar, Zachariah Defilipp, Pooja Khandelwal, Wael Saber, Stephen Spellman, Najla El Jurdi, Stephanie Lee, Zheng Zhou

Blood (2025) 146 (Supplement 1): 931.

https://doi.org/10.1182/blood-2025-931

Published: 2025

Journal Articles

Vδ2 unconventional T cells in the donor graft are associated with improved overall survival after unrelated donor allo-HCT for AML and MDS: An analysis from the DKMS and NMDP graft composition study

Blood (2025) 146 (Supplement 1): 1057.

https://doi.org/10.1182/blood-2025-1057

Published: 2025

Journal Articles

The MEASURE Genome Atlas: Acute Myeloid Leukemia at diagnosis and complete remission

Kai Yu, Laura Dillon, Jesse Tettero, Gege Gui, Rasha Al-Ali, Michael Grunwald, Elizabeth Krakow, Elizabeth Griffiths, Alexandra Gomez-Arteaga, Rahul Vedula, Melhem Solh, Amandeep Salhotra, Nelli Bejanyan, Lori Muffly, Antonio Jimenez-Jimenez, Michael Drazer, Yi-Bin Chen, Aaron Logan, Reena Jayani-Kosarzycki, Sophia Balderman, James Blachly, Brian Shaffer, Marc Schwartz, Cecilia Yeung, Lawrence Druhan, Vanessa Kennedy, Sandeep Gurbuxani, Melissa Tjota, Max Smith, Farah Sahoo, Dylan Barfield, Jim Guo, James Han, Jason Hu, Heejoon Jo, Vidya Kudlingar, Wilfred Li, Yutong Qiu, Pratheesh Sathyan, Sean Truong, Severine Catreux, Sam Ng, Khai Luong, Yunjiao Zhu, Reem Bahr, Jamie Diemer, Jianqun Kou, Stephanie Bo-Subait, Jackie Bjerke, Steven Devine, Bergetta Dietel, Christina Ferrone, Gabrielle Giammarino, Emily Heying, Emily Kolb, Danielle O'Donnell Vitali, Wael Saber, Stephen Spellman, Brenna Tesch, Jenny Vogel, Stephanie Waldvogel, Syreeta Weatherspoon, Jeffery Auletta, Christopher Hourigan

Blood (2025) 146 (Supplement 1): 455.

https://doi.org/10.1182/blood-2025-455

Published: 2025

Journal Articles

Germline genetic variants and post-HCT cytokine/chemokine milieu may identify those at higher risk of primary graft failure after allogeneic hematopoietic cell transplantation, a blood and marrow transplant clinical trials network (BMT CTN) study

Kirsten Williams, Jennifer Holter-Chakrabarty, Sara Vesely, Marie Gordon, Ashwin Koppayi, Yvonne Suessmuth, Iskra Pusic, John McCarty, Philip McCarthy, Asad Bashey, Gregory Yanik, Michelle Schoettler, Valerie Stewart, Sarita Layton, Stephen Spellman, Wael Saber, Christopher Porter, Lucy Godley

Blood (2025) 146 (Supplement 1): 4209.

https://doi.org/10.1182/blood-2025-4209

Published: 2025

Journal Articles

ACCELERATE: A platform protocol to investigate post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis in patients with hematologic malignancies undergoing mismatched unrelated donor peripheral blood stem cell transplantation

Sarah Smith, Heather Stefanski, Stephen Spellman, Joseph Stanek, Dillon Corrigan, Brent Logan, Bronwen Shaw, Rachel Cusatis, Erin Leckrone, Jeffery Auletta, Steven Devine

Blood (2025) 146 (Supplement 1): 6035.

https://doi.org/10.1182/blood-2025-6035

Published: 2025

Journal Articles

HLA mismatch-derived epitopes predict acute graft-versus-host disease risk after unrelated donor transplantation

Nicoletta Cieri, Yiren Shao, Luis Correa-Medero, Julia Keating, Meilun He, Yung-Tsi Bolon, Griffin Lawrence, Jerome Ritz, Robert Soiffer, Jenn Abelin, Donna Neuberg, Stephen Spellman, Catherine Wu

Blood (2025) 146 (Supplement 1): 4249.

https://doi.org/10.1182/blood-2025-4249

Published: 2025

Journal Articles

Phase II Study of post transplant cyclophosphamide-based graft versus host disease prophylaxis after HLA-mismatched unrelated donor transplantation and reduced intensity conditioning: Results from the NMDP-sponsored access expansion Study

Blood (2025) 146 (Supplement 1): 4232.

https://doi.org/10.1182/blood-2025-4232

Published: 2025

Journal Articles

Longer telomeres in donors aged ≥35 years reduce graft failure and non-relapse mortality after allogeneic HCT

Nico Gagelmann, Kyle Hebert, Thomas McGovern, Gabrielle Schmidt, Valerie Stewart, Donna Neuberg, Stephen Spellman, Jeffery Auletta, Steven Devine, Robert Soiffer, Immaculata De Vivo, Christopher Reilly, R. Coleman Lindsley

Blood (2025) 146 (Supplement 1): 373.

https://doi.org/10.1182/blood-2025-373

Published: 2025

Journal Articles

Impact of HLA alloimmunization on availability of HLA well matched and mismatched unrelated allogeneic hematopoietic cell donors for transplantation

Brian Shaffer, Amanda Blouin, Candice Rapoport, Deborah Wells, Stephanie Chinapen, Miguel-Angel Perales, Steven Devine, Jeffery Auletta, Heather Stefanski, Stephen Spellman, Martin Maiers

Blood (2025) 146 (Supplement 1): 2434.

https://doi.org/10.1182/blood-2025-2434

Published: 2025

Journal Articles

Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages

Blood (2022) 140 (24): 2533–2548.

https://doi.org/10.1182/blood.2022015790

Published: 2022

Includes: Supplemental data

Journal Articles

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Jason Dehn, Stephen Spellman, Carolyn K. Hurley, Bronwen E. Shaw, Juliet N. Barker, Linda J. Burns, Dennis L. Confer, Mary Eapen, Marcelo Fernandez-Vina, Robert Hartzman, Martin Maiers, Susana R. Marino, Carlheinz Mueller, Miguel-Angel Perales, Raja Rajalingam, Joseph Pidala

Blood (2019) 134 (12): 924–934.

https://doi.org/10.1182/blood.2019001212

Published: 2019

Journal Articles

Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant

Blood (2017) 130 (13): 1585–1596.

https://doi.org/10.1182/blood-2017-05-784637

Published: 2017

Includes: Supplemental data

Journal Articles

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease

Blood (2016) 128 (20): 2450–2456.

https://doi.org/10.1182/blood-2016-07-728063

Published: 2016

Includes: Supplemental data

Journal Articles

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

Blood (2014) 124 (16): 2596–2606.

https://doi.org/10.1182/blood-2014-05-576041

Published: 2014

Journal Articles

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33 + targets

Michelle K. Gleason, Julie A. Ross, Erica D. Warlick, Troy C. Lund, Michael R. Verneris, Andres Wiernik, Stephen Spellman, Michael D. Haagenson, Alexander J. Lenvik, Mark R. Litzow, Pearlie K. Epling-Burnette, Bruce R. Blazar, Louis M. Weiner, Daniel J. Weisdorf, Daniel A. Vallera, Jeffrey S. Miller

Blood (2014) 123 (19): 3016–3026.

https://doi.org/10.1182/blood-2013-10-533398

Published: 2014

Includes: Supplemental data

Journal Articles

Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy

Blood (2014) 123 (1): 133–140.

https://doi.org/10.1182/blood-2013-05-506253

Published: 2014

Includes: Supplemental data

Journal Articles

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

Blood (2013) 122 (21): 706.

https://doi.org/10.1182/blood.V122.21.706.706

Published: 2013

Journal Articles

Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Single Nucleotide Polymorphisms Do Not Impact Outcomes After Unrelated Donor Transplant: A Center For International Blood and Marrow Transplant Research Analysis

Salyka Sengsayadeth, MD, Tao Wang, PhD, Stephanie J. Lee, MD, MPH, Michael D. Haagenson, MS, Stephen Spellman, MBS, Marcelo A. Fernandez Viña, PhD, D(ABHI), Carlheinz R. Muller, MD, PhD, Michael R. Verneris, MD, Bipin N. Savani, MD, Madan Jagasia, MBBS, MS

Blood (2013) 122 (21): 710.

https://doi.org/10.1182/blood.V122.21.710.710

Published: 2013

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes at one year following transplantation: Results from the NMDP sponsored ACCESS study

Reduced chronic graft versus host disease after allogeneic HSCT with cryopreserved peripheral blood stem cell grafts: A CIBMTR analysis

Post-transplant cyclophosphamide based GVHD prophylaxis in HLA-matched related and unrelated donor hematopoietic cell transplantation in adults with hematologic malignancies undergoing myeloablative conditioning: A CIBMTR analysis of 8,272 participants

Vδ2 unconventional T cells in the donor graft are associated with improved overall survival after unrelated donor allo-HCT for AML and MDS: An analysis from the DKMS and NMDP graft composition study

The MEASURE Genome Atlas: Acute Myeloid Leukemia at diagnosis and complete remission

Germline genetic variants and post-HCT cytokine/chemokine milieu may identify those at higher risk of primary graft failure after allogeneic hematopoietic cell transplantation, a blood and marrow transplant clinical trials network (BMT CTN) study

ACCELERATE: A platform protocol to investigate post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis in patients with hematologic malignancies undergoing mismatched unrelated donor peripheral blood stem cell transplantation

HLA mismatch-derived epitopes predict acute graft-versus-host disease risk after unrelated donor transplantation

Phase II Study of post transplant cyclophosphamide-based graft versus host disease prophylaxis after HLA-mismatched unrelated donor transplantation and reduced intensity conditioning: Results from the NMDP-sponsored access expansion Study

Longer telomeres in donors aged ≥35 years reduce graft failure and non-relapse mortality after allogeneic HCT

Impact of HLA alloimmunization on availability of HLA well matched and mismatched unrelated allogeneic hematopoietic cell donors for transplantation

Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33 + targets

Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Single Nucleotide Polymorphisms Do Not Impact Outcomes After Unrelated Donor Transplant: A Center For International Blood and Marrow Transplant Research Analysis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only